Table 2 Procedure in the standard, non-personalized psychological treatment arm

1)

Patient is referred for participation in this trial via their treating doctor or via self-referral.

2)

Screening, baseline assessment (T0), and randomization.

3)

Intake interview. Following the standard protocols of the treatment for fear or cancer recurrence, fatigue, or depression, additional questionnaires need to be filled out.

4)

Results of additional assessments as part of the standard protocol are discussed.

5)

Start blended therapy for the symptom for which the score on the accompanying questionnaire is above the cutoff.

6)

Patient receives the evidence-based diagnosis-specific treatment protocol.

7)

At the end of treatment (approximately 6 months after intake), follow-up assessment (T1).

8)

12 months after intake, follow-up assessment (T2).